Colorado’s Life Sciences Raised $2.15B in 2024
Colorado’s life sciences ecosystem flourished in 2024, raising $2.15 billion, a 46% increase from 2023, marking the second time...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy FDA Warning Letter GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy manufacturing compliance Oncology Trials Opinion Parkinson's Disease Platform Trials protocol amendments Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Colorado’s life sciences ecosystem flourished in 2024, raising $2.15 billion, a 46% increase from 2023, marking the second time...
BiVACOR, a clinical-stage medical device company, has successfully completed the initial phase of its FDA Early Feasibility Study (EFS)...
Insitro, a machine learning-driven drug discovery company, achieved a milestone in its collaboration with Bristol Myers Squibb, receiving $25...
Holoclara, a biotechnology company, has launched its first-in-human Phase 1 clinical trial for HC002, an orally available small molecule...
Benchstrength, a New York City-based venture capital firm, has closed its first fund with investments from prominent institutions like...
CardioFocus, Inc. has initiated the VISION AF clinical trial, marking the first use of its investigational OptiShot™ Pulsed Field...
Scientists at City of Hope have identified a protein, YTHDF2, that helps blood cancer cells evade CAR T cell...
eClinical Solutions and Snowflake have partnered to integrate eClinical’s elluminate Clinical Data Cloud with the Snowflake AI Data Cloud....
Silexion Therapeutics is developing SIL-204, a next-generation siRNA therapy targeting a broad range of KRAS mutations prevalent in difficult-to-treat...
In this interview, we speak with Doug Cohen, CEO of IR Medtek, about their groundbreaking noninvasive cancer detection technology....